<?xml version="1.0" encoding="ISO-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://www.buytestosterones.net/testosterone-article-feed/delatestryl/">
        <title>Buy Testosterones</title>
        <description>'Delatestryl'</description>
        <link>http://www.buytestosterones.net/delatestryl/</link>
       <dc:date>2010-03-10T21:18:48+01:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---morning-alert-for-indevus-pharmaceuticals-inc."/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---current-research-on-indevus-pharmaceuticals-inc."/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---indevus-pharmaceuticals-inc-is-added-to-the-bellwether-watch-list."/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---analysis-of-indevus-pharmaceuticals-inc."/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---fundamental-review-for-indevus-pharmaceuticals-inc."/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals-closes-sale-of-delatestryl&amp;#174;-product-to-indevus-pharmaceuticals"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---indevus-announces-closing-of-delatestryl&amp;#174;-transaction"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals-agrees-to-sale-of-delatestryl&amp;#174;-to-indevus-pharmaceuticals"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---indevus-pharmaceuticals-announces-fiscal-2005-year-end-and-fourth-quarter-results;-company-acquires-rights-to-delatestryl&amp;#174;;-company-finalizes-nda-submission-plans-for-nebido&amp;#174;"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals,-inc.-announces-fda-approval-of-new-manufacturing-site-for-delatestryl,-savient's-injectable-testosterone-product"/>
            </rdf:Seq>
        </items>
    </channel>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---morning-alert-for-indevus-pharmaceuticals-inc.">
        <dc:format>text/html</dc:format>
        <title>M2 Presswire - Morning Alert for Indevus Pharmaceuticals Inc.</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---morning-alert-for-indevus-pharmaceuticals-inc.</link>
        <description>June 27, 2007 -- M2 PRESSWIRE-27 June 2007-Biotech News: Morning Alert for Indevus  Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD    RDATE:27062007...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---current-research-on-indevus-pharmaceuticals-inc.">
        <dc:format>text/html</dc:format>
        <title>M2 Presswire - Current Research on Indevus Pharmaceuticals Inc.</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---current-research-on-indevus-pharmaceuticals-inc.</link>
        <description>June  7, 2007 -- M2 PRESSWIRE-7 June 2007-Biotech News: Current Research on Indevus  Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD    RDATE:07062007...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---indevus-pharmaceuticals-inc-is-added-to-the-bellwether-watch-list.">
        <dc:format>text/html</dc:format>
        <title>M2 Presswire - Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list.</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---indevus-pharmaceuticals-inc-is-added-to-the-bellwether-watch-list.</link>
        <description>March 26, 2007 -- M2 PRESSWIRE-26 March 2007-Biotech News: Indevus Pharmaceuticals  Inc is Added to the Bellwether Watch list(C)1994-2007 M2 COMMUNICATIONS  LTD...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---analysis-of-indevus-pharmaceuticals-inc.">
        <dc:format>text/html</dc:format>
        <title>M2 Presswire - Analysis of Indevus Pharmaceuticals Inc.</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---analysis-of-indevus-pharmaceuticals-inc.</link>
        <description>March  2, 2007 -- M2 PRESSWIRE-2 March 2007-Biotech News: Analysis of Indevus  Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD    RDATE:02032007    Analysis of...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---fundamental-review-for-indevus-pharmaceuticals-inc.">
        <dc:format>text/html</dc:format>
        <title>M2 Presswire - Fundamental Review for Indevus Pharmaceuticals Inc.</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#m2-presswire---fundamental-review-for-indevus-pharmaceuticals-inc.</link>
        <description>December 12, 2006 -- M2 PRESSWIRE-12 December 2006-Biotech News: Fundamental Review for  Indevus Pharmaceuticals Inc(C)1994-2006 M2 COMMUNICATIONS LTD    RDATE:12122006...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals-closes-sale-of-delatestryl&amp;#174;-product-to-indevus-pharmaceuticals">
        <dc:format>text/html</dc:format>
        <title>Business Wire - Savient Pharmaceuticals Closes Sale of Delatestryl&amp;amp;#174; Product to Indevus Pharmaceuticals</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals-closes-sale-of-delatestryl&amp;#174;-product-to-indevus-pharmaceuticals</link>
        <description>January  9, 2006 -- Savient Pharmaceuticals Closes Sale of Delatestryl(R) Product to Indevus Pharmaceuticals.   EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc....</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---indevus-announces-closing-of-delatestryl&amp;#174;-transaction">
        <dc:format>text/html</dc:format>
        <title>Business Wire - Indevus Announces Closing of Delatestryl&amp;amp;#174; Transaction</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---indevus-announces-closing-of-delatestryl&amp;#174;-transaction</link>
        <description>January  9, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced the closing of the previously announced acquisition of the U.S....</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals-agrees-to-sale-of-delatestryl&amp;#174;-to-indevus-pharmaceuticals">
        <dc:format>text/html</dc:format>
        <title>Business Wire - Savient Pharmaceuticals Agrees to Sale of Delatestryl&amp;amp;#174; to Indevus Pharmaceuticals</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals-agrees-to-sale-of-delatestryl&amp;#174;-to-indevus-pharmaceuticals</link>
        <description>December 13, 2005 -- EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNTE) an emerging specialty pharmaceuticals company focused on developing,...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---indevus-pharmaceuticals-announces-fiscal-2005-year-end-and-fourth-quarter-results;-company-acquires-rights-to-delatestryl&amp;#174;;-company-finalizes-nda-submission-plans-for-nebido&amp;#174;">
        <dc:format>text/html</dc:format>
        <title>Business Wire - Indevus Pharmaceuticals Announces Fiscal 2005 Year End and Fourth Quarter Results; Company Acquires Rights to Delatestryl&amp;amp;#174;; Company Finalizes NDA Submission Plans for NEBIDO&amp;amp;#174;</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---indevus-pharmaceuticals-announces-fiscal-2005-year-end-and-fourth-quarter-results;-company-acquires-rights-to-delatestryl&amp;#174;;-company-finalizes-nda-submission-plans-for-nebido&amp;#174;</link>
        <description>December 13, 2005 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced its consolidated results of operations for the fiscal year and the...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals,-inc.-announces-fda-approval-of-new-manufacturing-site-for-delatestryl,-savient's-injectable-testosterone-product">
        <dc:format>text/html</dc:format>
        <title>Business Wire - Savient Pharmaceuticals, Inc. Announces FDA Approval of New Manufacturing Site for Delatestryl, Savient's Injectable Testosterone Product</title>
        <link>http://www.buytestosterones.net/testosterone-article/delatestryl/#business-wire---savient-pharmaceuticals,-inc.-announces-fda-approval-of-new-manufacturing-site-for-delatestryl,-savient's-injectable-testosterone-product</link>
        <description>September  8, 2003 -- Business Editors/Health/Medical Writers   Business Editors/Health/Medical Writers
  BIOWIRE2K
  EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 8,...</description>
    </item>
</rdf:RDF>
